47.61  -0.44 (-0.92%)		03-05 16:00
Open: 46.73 High: 47.73 Volume: 19,047		Pre. Close: 48.05 Low: 45.65 Market Cap: 155(M)

Short term
Mid term
Targets	6-month :	58.96	1-year :	68.86
Resists	First :	50.47	Second :	58.96
Pivot price	42.65
Supports	First :	42.19	Second :	37.06
MAs	MA(5) :	46.72	MA(20) :	41.64
	MA(100) :	37.37	MA(250) :	42.32
MACD	MACD :	1.9	Signal :	1
%K %D	K(14,3) :	85.1	D(3) :	90.4
RSI	RSI(14): 70.9
52-week	High :	70.26	Low :	23.46

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PDEX ] has closed below upper band by 13.0%. Bollinger Bands are 50% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	47.76 - 48	48 - 48.19
Low:	45.09 - 45.35	45.35 - 45.54
Close:	47.2 - 47.63	47.63 - 47.97

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Thu, 29 Jan 2026
PRO DEX INC SEC 10-Q Report - TradingView

Sun, 25 Jan 2026
With 37% ownership, Pro-Dex, Inc. (NASDAQ:PDEX) has piqued the interest of hedge funds investors - Yahoo Finance

Sat, 17 Jan 2026
Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount (NASDAQ:PDEX) - Seeking Alpha

Sat, 10 Jan 2026
We Think Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt With Ease - simplywall.st

Thu, 08 Jan 2026
Pro-Dex Valuation Is Attractive Despite Customer Risk (NASDAQ:PDEX) - Seeking Alpha

Mon, 22 Dec 2025
Pro-Dex Announces Contract Extension With Largest Customer - Nasdaq

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	3 (M)
Shares Float	2 (M)
Held by Insiders	36.6 (%)
Held by Institutions	32.1 (%)
Shares Short	246 (K)
Shares Short P.Month	206 (K)

EPS	3.41
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	12.97
Profit Margin	15.7 %
Operating Margin	17.4 %
Return on Assets (ttm)	11.5 %
Return on Equity (ttm)	30.8 %
Qtrly Rev. Growth	11.1 %
Gross Profit (p.s.)	6.35
Sales Per Share	22.46
EBITDA (p.s.)	3.92
Qtrly Earnings Growth	8.1 %
Operating Cash Flow	6 (M)
Levered Free Cash Flow	6 (M)

PE Ratio	13.96
PEG Ratio	0
Price to Book value	3.67
Price to Sales	2.11
Price to Cash Flow	23.65

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.